Cargando…

Update on the management of colchicine resistant Familial Mediterranean Fever (FMF)

BACKGROUND: Familial Mediterranean Fever (FMF), an autoinflammatory disease, is characterized by self-limited inflammatory attacks of fever and polyserositis along with high acute phase response. Although colchicine remains the mainstay in treatment, intolerance and resistance in a certain portion o...

Descripción completa

Detalles Bibliográficos
Autores principales:	El Hasbani, Georges, Jawad, Ali, Uthman, Imad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794843/ https://www.ncbi.nlm.nih.gov/pubmed/31615541 http://dx.doi.org/10.1186/s13023-019-1201-7

Ejemplares similares

The patient experience of Colchicine Resistant-Familial Mediterranean Fever (cr-FMF)
por: Dandekar, P, et al.
Publicado: (2015)

Epidemiology of colchicine resistant Familial Mediterranean Fever disease (CrFMF) in Turkey
por: Turgay, S, et al.
Publicado: (2015)

The familial Mediterranean fever (FMF) 50 score: does it work in a controlled clinical trial? Re-analysis of the trial of rilonacept for patients with colchicine resistant or intolerant FMF
por: Hashkes, P, et al.
Publicado: (2015)

Colchicine plus Dapsone in Colchicine‐Resistant FMF Patients
por: Salehzadeh, Farhad, et al.
Publicado: (2019)

Cupping (Hijama) in Rheumatic Diseases: The Evidence
por: Hasbani, Georges El, et al.
Publicado: (2021)

Rheumatoid Arthritis and Familial Mediterranean Fever or Sacroiliitis Accompanied by FMF
por: Şahin, Ali, et al.
Publicado: (2013)

Musculoskeletal Manifestations of Sarcoidosis
por: Hasbani, Georges El, et al.
Publicado: (2022)

Colchicine therapy in children with FMF
por: Knieper, A-M, et al.
Publicado: (2015)

The effect of Anakinra on Quality-of-Life in a family with colchicine-resistant FMF
por: van der Hilst, J, et al.
Publicado: (2015)

COVID-19, Antiphospholipid Antibodies, and Catastrophic Antiphospholipid Syndrome: A Possible Association?
por: El Hasbani, Georges, et al.
Publicado: (2020)

Dimethylaminoparthenolide (DMAPT) as an alternative approach for treatment of Familial Mediterranean Fever (FMF)
por: Mosayebian, Ali, et al.
Publicado: (2021)

Familial Mediterranean Fever (FMF) before the age of one year
por: Delion, F, et al.
Publicado: (2008)

Gut Microbiota between Environment and Genetic Background in Familial Mediterranean Fever (FMF)
por: Di Ciaula, Agostino, et al.
Publicado: (2020)

Rilonacept (IL-1 TRAP) for treatment of colchicine resistant familial mediterranean fever (FMF): a randomized, multicenter double-blinded, alternating treatment trial
por: Hashkes, PJ, et al.
Publicado: (2011)

Compliance to colchicine treatment and disease activity in Familial Mediterranean Fever (FMF) patients in Middle/Black Sea Region of Turkey (in Çorum region)
por: Karaaslan, Y, et al.
Publicado: (2015)

Is adhesive capsulitis of the shoulder a form of complex regional pain syndrome type I?
por: Hasbani, Georges El, et al.
Publicado: (2020)

Painless swelling of proximal interphalangeal joints in an adolescent child with preserved function and normal acute phase reactants
por: EL HASBANI, Georges, et al.
Publicado: (2020)

The effect of wet-cupping therapy (hijama) in modulating autoimmune activity of Hashimoto’s thyroiditis.: A pilot controlled study
por: Jawad, Ali S., et al.
Publicado: (2022)

P01-031 – Anakinra for colchicine resistant FMF
por: Ben-Zvi, I, et al.
Publicado: (2013)

PW01-025 – Definition of colchicine resistance in FMF
por: Demirkaya, E, et al.
Publicado: (2013)

OR7-005 – Canakinumab in childhood colchicine resistant FMF
por: Hashkes, PJ, et al.
Publicado: (2013)

A survey of resistance to colchicine treatment for French patients with familial Mediterranean fever
por: Corsia, Alice, et al.
Publicado: (2017)

The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever
por: Calligaris, Lorenzo, et al.
Publicado: (2007)

Feasibility of canakinumab withdrawal in colchicine-resistant familial Mediterranean fever
por: Sener, Seher, et al.
Publicado: (2023)

How long is the diagnosis of Familial Mediterranean Fever (FMF) delayed in a region where FMF is common in Turkey?
por: Karaaslan, Y, et al.
Publicado: (2015)

Attacks of severe dysmenorrhea as the sole manifestation of Familial Mediterranean Fever (FMF)
por: Vitale, A, et al.
Publicado: (2008)

Erythema nodosum in Behçet’s disease in remission: Think COVID-19?
por: El Hasbani, Georges, et al.
Publicado: (2023)

PW01-002 – Colchicine resistant FMF in Turkish children
por: Eroglu, FK Kara, et al.
Publicado: (2013)

PW01-015 – Canakinumab in adults with colchicin resistant FMF
por: Gül, A, et al.
Publicado: (2013)

IL1-blocking therapy in colchicine-resistant familial Mediterranean fever
por: Köhler, Birgit Maria, et al.
Publicado: (2018)

Effectiveness of Canakinumab Treatment in Colchicine Resistant Familial Mediterranean Fever Cases
por: Yücel, Burcu Bozkaya, et al.
Publicado: (2021)

Behçet Disease (BD) in two siblings affected with Familial Mediterranean Fever (FMF)
por: Calcagno, G, et al.
Publicado: (2008)

Familial Mediterranean Fever in Iran: A Report from FMF Registration Center
por: Salehzadeh, Farhad
Publicado: (2015)

P01-027 – Normal HRV in colchicine-resistant FMF patients
por: Nussinovitch, U, et al.
Publicado: (2013)

Quality of life changes with canakinumab therapy in adults with colchicine resistant FMF
por: Gul, A, et al.
Publicado: (2015)

Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever
por: Gül, Ahmet, et al.
Publicado: (2015)

Intestinal malrotation as a misdiagnosis of pediatric colchicine resistant familial Mediterranean fever
por: Heshin-Bekenstein, Merav, et al.
Publicado: (2015)

Colchicine-Resistant Familial Mediterranean Fever With Depressive State Successfully Treated With Escitalopram
por: Toshida, Masamitsu, et al.
Publicado: (2021)

Endocan: A Novel Marker for Colchicine Resistance in Familial Mediterranean Fever Patients?
por: Omma, Ahmet, et al.
Publicado: (2021)

Vacuolar Interface Dermatitis as a Histologic Reaction Pattern of Sjögren’s Syndrome: A Case Report
por: El Hasbani, Georges, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_21q6uuobgbam8josi3nq4ep9qs